Aligos Therapeutics, Inc .: Jefferies & Co. lowers opinion to neutral

0


Zonebourse with MT Newswires 2022

All the news on ALIGOS THERAPEUTICS, INC.

Analyst Recommendations on ALIGOS THERAPEUTICS, INC.

Turnover 2021 4.00 M
–
3.52 M
2021 net result -127 M
–
-112 M
Net debt 2021 –
–
–
PER 2021-1.24x
Yield 2021–
Capitalization 167 M
167 M
147 M
Capi. / CA 202141.7x
Capi. / CA 2022–
Nbr Employees86
Floating77.2%

Chart ALIGOS THERAPEUTICS, INC.
Hard :

Period:

Aligos Therapeutics, Inc.: Aligos Therapeutics, Inc. Technical Analysis Chart | Stock market

Technical analysis trends ALIGOS THERAPEUTICS, INC.

Short termMiddle termLong term
TrendsDeclineDeclineDecline

Evolution of the Profit and Loss Account

Sale

Purchase

Average recommendationACCUMULATE
Number of Analysts5
Last Closing Price

$ 3.91

Average course objective

$ 19.20

Deviation / Average Target 391%

Officers and Directors



Source link -88